Portfolio

Visionary startup, mid-cap, multinational corporation or venture investor,
when life science companies require strategic leadership, they trust Domann.

  • AeroGen/Fluid Propulsion Technologies
  • Amgen
  • Anergen
  • Athena Neurosciences
  • Baxter Biotech
  • Berlex Biosciences
  • BioGenex Labs
  • Celtrix Pharmaceuticals
  • Codon
  • Collagen Corporation
  • Coulter Pharmaceutical
  • Cygnus, Inc.
  • Genelabs Technologies
  • Hall Surgical-Zimmer
  • Mentor Corporation
  • Microcide Pharmaceuticals
  • Orquest, Inc.
  • Pangea Pharmaceuticals/Zycos
  • Paradigm Biosciences
  • Pharmacyclics
  • SangStat Medical
  • SciClone Pharmaceuticals
  • SyStemix, Inc.
  • Synteni
  • Thermolase
  • Tularik
  • XOMA Corporation
  • Acologix, Inc.
  • Actimis Pharmaceuticals
  • Alpha Therapeutic Corporation
  • Amira Medical
  • Angstrom Pharmaceuticals
  • Anosys, Inc.
  • AP Cells
  • Arriva Pharmaceuticals
  • Aventis Gencell
  • Aviron, Inc.
  • Avidia
  • Berlex Biosciences
  • BioMedicines, Inc.
  • BioSeek, Inc.
  • Boston Scientific/TARGET
  • Bridge Laboratories
  • CelTor Biosystems
  • Celtrix Pharmaceuticals
  • Centaur Pharmaceuticals
  • Connetics Corporation
  • Desmos, Inc.
  • Digital Gene Technologies
  • Hyseq, Inc.
  • Iconix Pharmaceuticals, Inc.
  • Inhale Therapeutic Systems/Nektar
  • La Jolla Pharmaceutical Company
  • LumMed Inc.
  • Myogen Inc.
  • NeuroStar International, Inc.
  • Novalar Pharmaceuticals, Inc.
  • Nuvelo, Inc.
  • Omeros Corporation
  • OncoStar International, Inc.
  • Osprey Pharmaceuticals
  • Ossur
  • Plexxus Vaccines
  • PRA International
  • Progenitor, Inc.
  • Prometheus Laboratories
  • Sang/Stat Medical
  • Signature Biosciences
  • Synpac-NC
  • Target Protein Technologies
  • Tularik
  • The Vaccine Company
  • Valentis, Inc.
  • VaxGen, Inc
  • VIVUS, Inc.
  • Zyomyx, Inc.
  • Acologix, Inc.
  • aFRAXis, Inc
  • Alcobra, Ltd.
  • Ambit Biosciences
  • Aratana Therapeutics
  • Archimedes Therapeutics
  • Arcturus Therapeutics
  • ArmaGen
  • Aristea Therapeutics
  • Assembly Biosciences
  • Avexegen Therapeutics
  • Canaan Venture Partners
  • Catalyst Biosciences
  • Celladon Corporation
  • Cellastra
  • Cellectar Biosciences/Novelos
  • Cellerant Therapeutics
  • ChemioCare
  • COI Pharma
  • Cortexyme
  • Cypher Genomics
  • CytomX Therapeutics
  • Dart Neuroscience/Helicon Therapeutics
  • Deltanoid Pharmaceuticals
  • DeNovo Sciences
  • DepoMed
  • ENDECE Neural
  • Exokeryx
  • FluGen
  • Gemphire Therapeutics
  • Graybug Vision
  • Gregor Diagnostics
  • Independa
  • JHL Biotech Taiwan
  • John Wayne Cancer Institute
  • KemPharm
  • NantKwest/Conkwest
  • Naurex
  • Neuraltis Pharmaceuticals
  • Neurana Therapeutics
  • Nodality, Inc.
  • Nuon Therapeutics
  • Onyx Pharmaceuticals
  • Osprey Pharmaceuticals
  • Parvus Therapeutics
  • AIQ Solutions
  • AltaThera Pharmaceuticals
  • Ankasa Regenerative Therapeutics
  • Arcturus Therapeutics
  • Aristea Therapeutics
  • Cleave Biosciences
  • Cortexyme, Inc.
  • Crinetics Pharmaceuticals
  • Estrigenix Therapeutics
  • Exokeryx, Inc.
  • Inozyme Pharma
  • Interactome Biotherapeutics
  • Lengo Therapeutics
  • MBX Biosciences
  • Medera Bio/Sardocor
  • Medikine, Inc.
  • Neurana Pharma
  • Oncolytics Biotech
  • OnLume Surgical
  • Pharmajet
  • Regel Therapeutics
  • ShouTi/Structure Therapeutics
  • Synthorx, Inc.
  • TAI Diagnostics
  • UW Health/Isthmus Project
  • Volta Medical

The Domann Organization-Domann the Board Room Inc.
Midwest Practice Fact Sheet

The Domann Organization, Domann-The Board Room Inc. established a presence in the Midwest in 2009 representing the Life Science Community. Bill Domann, Founder & CEO was raised and educated in Wisconsin and founded the Domann Organization in San Francisco, 1988 during the Life Sciences infancy.

Bill’s 40 plus years of retained executive search experience, network, relationships built on trust, transparency and success are the foundation for Domann-the Board Room Inc. Roles are Executive Chair, Independent Board Members, Chief Executive Officer “C” Suite leadership, Strategic Advisors.

Domann also makes introductions to the Investment Community that we have built and worked with for over the past 25 plus years. Domann sponsors and supports key Investment Conferences in the region. Wisconsin Technology Council Early-Stage Symposium & Wisconsin Entrepreneur’s Conference, Invest Midwest Venture Capital Forum, Michigan Growth Capital Symposium, MidAmerica Healthcare Venture Forum, BioForward-Bioscience Vision Summit and MRUN(Midwest Research University Network).

Domann supports BioForward, Bill served as a Director, 2014-2016, the Wisconsin Technology Council, MICHBIO, iBIO, Indiana Health Industry Forum.

85% of Domann’s Client base are Seed, Series A Life Science start-ups.

Domann Midwest Search Activity 2010 to Present

  • AIQ Solutions
  • Aratana Therapeutics
  • Assembly Biosciences
  • AltaThera Pharmaceuticals
  • Cellectar Biosciences
  • Deltanoid Pharmaceuticals
  • DeNovo Sciences
  • ENDECE Neural, LLC
  • Estrigenix Therapeutics
  • FluGen, Inc.
  • Gemphire Therapeutics
  • Gregor Diagnostics
  • Interactome Biotherapeutics
  • Kempharm, Inc.
  • MBX Biosciences
  • Naurex, Inc.
  • OnLume Surgical, Inc.
  • Radiant Fabricant
  • Swift Biosciences
  • TAI Diagnostics
  • UW Health/Isthmus Project

DOMANN – Life Science Leadership since our founding in San Francisco, 1988, has built our practice by professionally and transparently representing our clients, consistently delivering leadership talent who make an impact for our clients, investors, and the candidates we place. For additional information or to discuss search needs please contact Bill Domann at bill@domann.net or Jovanna Bost at jbost@domann.net . To learn more about our firm please visit our website at: www.domann.net